EVITA clinical trial evaluates oral vitamin C for pre-cancerous blood disorders
Vitamin C boosts the activity of cellular proteins called TET enzymes that help control which genes are turned on or off.
Read original article on The Medical News →Related news
-
Virtual reality and music may help lower blood pressure during emergencies
United Kingdom
-
Drone-delivered AEDs could reduce defibrillation delays after cardiac arrest
United Kingdom
-
MD Anderson researchers showcase new findings in radiation oncology at ASTRO 2026
United Kingdom
-
UCLA researchers present new radiation advances at ASTRO 2026
United Kingdom
-
AI-based model predicts glioblastoma recurrence to guide targeted treatment
United Kingdom
-
AI-generated video summaries can reshape people's memories of events
United Kingdom
-
Biosensors could transform rapid monitoring of multiple waterborne pathogens
United Kingdom
-
Toxoplasma remodels host cell surfaces to trigger invasion
United Kingdom